Icon (ICLR) Revenue (2009 - 2026)
Icon's (ICLR) quarterly Revenue came in at $2.1 billion in Q2 2026, up 1.2% year-over-year from $2.0 billion in Q2 2025, and up 1.45% quarter-over-quarter from $2.0 billion in Q1 2026.
Analysis
Icon (ICLR) Revenue (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Revenue for 18 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Revenue rose 1.2% year-over-year to $2.1 billion in Q2 2026; TTM through Jun 2026 was $8.3 billion, a 1.31% increase from a year earlier, with the FY2025 full-year figure at $8.3 billion, up 0.76% from the prior year.
- Revenue was $2.1 billion for Q2 2026 at Icon, up from $2.0 billion in the prior quarter.
- Over five years, Revenue peaked at $2.1 billion in Q2 2024 and troughed at $1.9 billion in Q1 2022.
- A 5-year average of $2.0 billion and a median of $2.0 billion in 2025 frame the typical range for Revenue.
- Across the five-year window, Revenue jumped 122.14% in 2022 and declined 3.82% in 2025, its largest moves.
- Over 5 years, Revenue stood at $2.0 billion in 2022, then increased by 4.01% to $2.0 billion in 2023, then grew by 1.04% to $2.1 billion in 2024, then rose by 2.46% to $2.1 billion in 2025, then retreated by 2.32% to $2.1 billion in 2026.
- The last three Revenue figures came in at $2.1 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 4.37 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 707.33 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.06 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.00 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 678.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 20.16 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 15.23 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.75 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 18,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.06 Bn |
| Mar 31, 2026 | 2.03 Bn |
| Dec 31, 2025 | 2.11 Bn |
| Sep 30, 2025 | 2.04 Bn |
| Jun 30, 2025 | 2.04 Bn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 2.06 Bn |
| Sep 30, 2024 | 2.03 Bn |
| Jun 30, 2024 | 2.12 Bn |
| Mar 31, 2024 | 2.09 Bn |
| Dec 31, 2023 | 2.04 Bn |
| Sep 30, 2023 | 2.06 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 1.98 Bn |
| Dec 31, 2022 | 1.96 Bn |
| Sep 30, 2022 | 1.94 Bn |
| Jun 30, 2022 | 1.94 Bn |
| Mar 31, 2022 | 1.90 Bn |
| Dec 31, 2021 | 1.89 Bn |
| Sep 30, 2021 | 1.87 Bn |